Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01500096 · ClinicalTrials.gov registry record · Phase 2
American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
NCT01500096: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT01500096 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01500096, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether American ginseng is effective in the treatment of HIV-associated fatigue.
Interventions
- DRUG American ginseng
- DIETARY_SUPPLEMENT Placebo for American ginseng
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01500096
The ClinicalTrials.gov registry entry for NCT01500096 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which American ginseng is the first listed.
NCT01500096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01500096 about?
NCT01500096 is a clinical study titled "American Ginseng to Improve HIV-Associated Fatigue: A Randomized, Placebo-Controlled, Parallel Design, Multiple-Dose Clinical Trial". The purpose of this study is to determine whether American ginseng is effective in the treatment of HIV-associated fatigue.
What is the current status of trial NCT01500096?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2013-02. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01500096?
The interventions under investigation include: American ginseng (DRUG), Placebo for American ginseng (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01500096?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.